178 related articles for article (PubMed ID: 23362525)
1. Incidental venous thromboembolism in oncology patients.
Khorana AA; O'Connell C; Agnelli G; Liebman HA; Lee AY;
J Thromb Haemost; 2012 Dec; 10(12):2602-4. PubMed ID: 23362525
[No Abstract] [Full Text] [Related]
2. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH.
Di Nisio M; Lee AY; Carrier M; Liebman HA; Khorana AA;
J Thromb Haemost; 2015 May; 13(5):880-3. PubMed ID: 25714858
[No Abstract] [Full Text] [Related]
3. Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
Rouzaud D; Alexandra JF; Chauchard M; Delon M; Dossier A; Chauveheid MP; Perozziello A; Papo T; Sacre K
Thromb Res; 2016 Aug; 144():116-8. PubMed ID: 27322086
[No Abstract] [Full Text] [Related]
4. Is there benefit in extensive screening for cancer in patients with unprovoked venous thromboembolism?
Mwirigi A; McDonald V; Shapiro S; Hunt BJ; Young J; Glaves R; Breen K
Thromb Res; 2015 Dec; 136(6):1332-3. PubMed ID: 26553016
[No Abstract] [Full Text] [Related]
5. Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer.
Dentali F; Ageno W; Giorgi Pierfranceschi M; Imberti D; Malato A; Nitti C; Salvi A; Siragusa S; Squizzato A; Vitale J; Agnelli G
J Thromb Haemost; 2011 May; 9(5):1081-3. PubMed ID: 21410640
[No Abstract] [Full Text] [Related]
6. Evidence-based mini-review: should all patients with idiopathic venous thromboembolic events be screened extensively for occult malignancy?
Rosovsky R; Lee AY
Hematology Am Soc Hematol Educ Program; 2010; 2010():150-2. PubMed ID: 21239785
[No Abstract] [Full Text] [Related]
7. Recurrent Venous Thromboembolism in Two Patients With Cancer Taking Rivaroxaban.
Theodorou JM; Patel Y; Ford P
J Pharm Pract; 2017 Jun; 30(3):381-384. PubMed ID: 27026636
[TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients.
van der Hulle T; den Exter PL; Planquette B; Meyer G; Soler S; Monreal M; Jiménez D; Portillo AK; O'Connell C; Liebman HA; Shteinberg M; Adir Y; Tiseo M; Bersanelli M; Abdel-Razeq HN; Mansour AH; Donnelly OG; Radhakrishna G; Ramasamy S; Bozas G; Maraveyas A; Shinagare AB; Hatabu H; Nishino M; Huisman MV; Klok FA
J Thromb Haemost; 2016 Jan; 14(1):105-13. PubMed ID: 26469193
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study.
Giustozzi M; Connors JM; Ruperez Blanco AB; Szmit S; Falvo N; Cohen AT; Huisman M; Bauersachs R; Dentali F; Becattini C; Agnelli G
J Thromb Haemost; 2021 Nov; 19(11):2751-2759. PubMed ID: 34260816
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy.
Jones A; Stockton DL; Simpson AJ; Murchison JT
Br J Cancer; 2009 Sep; 101(5):840-2. PubMed ID: 19654574
[TBL] [Abstract][Full Text] [Related]
11. Treatment of venous thromboembolism in cancer patients.
Lee AY
Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
[TBL] [Abstract][Full Text] [Related]
12. Single drug regimen for treatment of acute venous thromboembolism in oncology patients.
Khajuria A
Br J Hosp Med (Lond); 2014 Mar; 75(3):176-7. PubMed ID: 24696880
[No Abstract] [Full Text] [Related]
13. Cancer and venous thrombosis: current comprehensions and future perspectives.
Lauw MN; van Doormaal FF; Middeldorp S; Buller HR
Semin Thromb Hemost; 2013 Jul; 39(5):507-14. PubMed ID: 23629821
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolic disease.
Streiff MB; Bockenstedt PL; Cataland SR; Chesney C; Eby C; Fanikos J; Fogarty PF; Gao S; Garcia-Aguilar J; Goldhaber SZ; Hassoun H; Hendrie P; Holmstrom B; Jones KA; Kuderer N; Lee JT; Millenson MM; Neff AT; Ortel TL; Smith JL; Yee GC; Zakarija A
J Natl Compr Canc Netw; 2011 Jul; 9(7):714-77. PubMed ID: 21715723
[No Abstract] [Full Text] [Related]
15. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
[TBL] [Abstract][Full Text] [Related]
16. Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis.
Caiano L; Carrier M; Marshall A; Young AM; Ageno W; Delluc A; Wang TF
J Thromb Haemost; 2021 Oct; 19(10):2468-2479. PubMed ID: 34161655
[TBL] [Abstract][Full Text] [Related]
17. Cancer Screening in Patients with Idiopathic Venous Thromboembolism--a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis.
Matzdorff A; Riess H; Bergmann F; Bisping G; Koschmieder S; Parmentier S; Petrides PE; Sosada M
Oncol Res Treat; 2015; 38(9):454-8. PubMed ID: 26407062
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence, indication and compliance with the recommendations of prescription of low molecular weight heparin in oncology].
Danklou J; Strobbe G; Delbey S; Lefebvre-Kuntz D; Marliot G
Bull Cancer; 2015 Nov; 102(11):898-905. PubMed ID: 26506036
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of venous thromboembolism in cancer: a silent echo from local events?
Gezelius E; Belting M
Biomark Med; 2019 May; 13(7):507-509. PubMed ID: 31140831
[No Abstract] [Full Text] [Related]
20. [Cancer and venous thromboembolism: an old association with new scenarios].
Lecumberri R; Rocha E
Med Clin (Barc); 2009 Oct; 133(14):545-6. PubMed ID: 19651419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
